Electra Therapeutics, Inc. (ETRA)

NASDAQ

$14.40

$+0.62

(+4.51%)

Pre-Market

Electra Therapeutics, Inc. (ETRA) Live Price Chart

Last updated: ⁦2026-09-21 10:43:20⁩. Prices reflect the latest pre-market trading data. Stock price data is sourced from Massive.

Summary

Electra Therapeutics, Inc. (ETRA) operates in the -- sector and is listed on NASDAQ. The stock is currently priced at $14.40, with a market capitalisation of $809.58M and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $13.25 to $15.50. This page covers its latest market performance, valuation, price trends and company information.

Key Market Data

Market Cap	$809.58M
Open	$13.78
Day's High	$15.50
Day's Low	$13.25
Previous Close	$13.25
Volume	1.07K
Average Volume	5.12M
P/E Ratio	--
52-Week High	$15.50
52-Week Low	$13.25
Dividend Yield	--
Earnings Date	--

Electra Therapeutics, Inc. (ETRA) Pre-Market Stock Price

Electra Therapeutics, Inc. (ETRA) is trading at $14.40 in pre-market trading as of 2026-09-21 10:08:00, up 8.68% ($1.15) from the previous close of $13.25

Pre-market trading shows how investors are pricing ETRA before the regular session opens. The current pre-market price is above the previous close, indicating positive early trading sentiment.

Electra Therapeutics, Inc. (ETRA) 7-Day Stock Price Change

Over the past seven days, Electra Therapeutics, Inc. (ETRA) moved from $13.25 to $14.40, representing a gain of 8.68% ($1.15).

The stock traded between $13.25 and $15.50 during the period. The latest price is near the middle of the 7-day range, indicating strong upward.

The average daily volume was 5.12 million shares, -- versus the previous seven-day period, indicating -- trading activity.

ETRA 52-Week Price Position

Position in Range: 51.1%

52W Low$13.25

52W High$15.50

ETRA is currently trading at $14.40, placing it 51.1% of the way from its 52-week low of $13.25 to its 52-week high of $15.50. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.

What is Electra Therapeutics, Inc. (ETRA)?

Electra Therapeutics Inc is a late clinical-stage biopharmaceutical company focused on pioneering a new class of precision medicines for the treatment of immune-mediated diseases and cancer.

Electra Therapeutics, Inc. Information

Exchange	NASDAQ
Company Website	https://www.electra-therapeutics.com

How to Buy Electra Therapeutics, Inc. (ETRA) Stock on MEXC

Eligible investors can buy real shares of Electra Therapeutics, Inc. (ETRA) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.

Step 1: Open and Verify Your RealStocks Account

Log in to the MEXC App, go to Trade → RealStocks, and select Open Account. Complete the required account-opening and identity verification process with MEXC's partner licenced broker.

Step 2: Transfer USDT to Your RealStocks Account

Go to Wallets → RealStocks and transfer USDT from your Spot Account to your RealStocks Account. RealStocks are quoted in USD, while account funding can be completed using USDT.

Step 3: Search for ETRA and Place Your Order

Open the RealStocks trading page and search for ETRA. Select a market or limit order, enter the price and quantity as required, review the order details, and submit your order. Once filled, the corresponding real shares will be held in your RealStocks Account.

Frequently Asked Questions (FAQ)

1.What is Electra Therapeutics, Inc. (ETRA) share price today?

Electra Therapeutics, Inc. (ETRA) is currently trading at $ 14.40, up 8.68% ($1.15) from the previous close of $ 13.25. Intraday prices update in real time during regular trading hours.

2.Is ETRA stock going up or down today?

As of 2026-09-21 10:08:00, ETRA is trading at $ 14.40, up 8.68% ($1.15) from its previous close of $ 13.25. The stock has traded between $ 13.25 and $ 15.50 during today’s regular session. Past price movements do not guarantee future results.

3.What is ETRA pre-market price?

As of 2026-09-21 10:08:00, ETRA is trading at $ 14.40 in pre-market trading, up 8.68% ($1.15) from the previous close of $ 13.25. Pre-market prices reflect trading activity before the regular session opens and may experience lower liquidity and higher volatility.

4.What is ETRA after-hours price?

As of 2026-09-21 10:08:00, ETRA is trading at -- in after-hours trading, -- from the regular-session close of $ 13.25. After-hours prices may differ from the regular session's opening price due to lower liquidity and wider bid-ask spreads.

5.Is ETRA stock trading now?

ETRA trades on the NASDAQ exchange during regular hours, Monday through Friday, 9:30 AM to 4:00 PM ET, excluding public holidays. Pre-market and after-hours trading are also available through select brokers outside these hours.

6.Where does ETRA sit relative to its 52-week high and low?

Over the past 52 weeks, ETRA has traded between a low of $ 13.25 and a high of $ 15.50. At $ 14.40, the stock is positioned 51.1% of the way from its 52-week low to its 52-week high, providing context for its current price within the one-year trading range.

7.What sector is Electra Therapeutics, Inc. in?

Electra Therapeutics, Inc. (ETRA) operates in the -- sector. Sector classification helps investors compare it with companies exposed to similar market trends and competitive conditions.

8.What is Electra Therapeutics, Inc.'s market capitalisation and where is it listed?

Electra Therapeutics, Inc. is listed on the NASDAQ exchange with a market capitalisation of $ 809.58M. Market cap reflects the total market value of all outstanding shares and is commonly used to classify stocks by size.

9.How is ETRA valued in terms of P/E ratio and EPS?

ETRA trades at a P/E ratio of --, based on trailing-twelve-month EPS of --. P/E ratio compares the stock price to earnings per share and is a common starting point for assessing valuation relative to peers.

10.Does Electra Therapeutics, Inc. pay a dividend?

Electra Therapeutics, Inc. pays an indicated annual cash dividend of -- per share, with a current dividend yield of --% based on the latest share price. Dividend policies are subject to change at the board's discretion.